PMID- 36540586 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230214 IS - 1841-9038 (Print) IS - 2069-6116 (Electronic) IS - 1841-9038 (Linking) VI - 17 IP - 3 DP - 2022 Sep TI - Association of Serum Magnesium with Insulin Indices in Patients with Type 2 Diabetes Mellitus. PG - 596-601 LID - 10.26574/maedica.2022.17.3.596 [doi] AB - Introduction: Magnesium has a direct impact on glucose metabolism since it is a cofactor for numerous energy-metabolizing enzymes. Hypomagnesemia has been linked to poor glycemic control and a range of diabetes-related long-term complications. This study aimed to assess the association between blood magnesium levels and insulin sensitivity indices in patients with type 2 diabetes mellitus (T2DM). Material and methods:Two hundred newly diagnosed T2DM patients aged over 40 years were recruited after excluding those with a history of heart failure, kidney illness, liver disease, hypothyroidism, ascites, pregnancy, tumors, and complications such as diabetic ketoacidosis. Fasting glucose, serum magnesium, serum insulin, serum urea and creatinine were measured. Patients were divided into two groups based on their serum magnesium levels. Results:There were no age or sex differences between the subjects of the two groups. Participants in the group with low magnesium had significantly high fasting blood sugar (FBS), postprandial blood sugar (PPBS), glycated hemoglobin (HbA1c), serum insulin, homeostasis model assessment-estimated insulin resistance (HOMA-IR) (P < 0.001). The multivariable logistic regression analysis showed significant associations with PPBS [odds ratio (OR) 0.98 (95% CI 0.97-0.99)], HbA1c [OR 0.05 (95% CI=0.005-0.55)] and creatinine [OR 0.004 (95% CI=0.00-0.074)]. Correlation statistics showed a negative correlation between magnesium and PPBS (r =-0.204), HOMA-IR (r = -0.819) and creatinine (r = -0.151). Conclusion:Serum magnesium levels have a negative correlation with FBS and PPBS, as well as HOMA-IR. It may well be essential to include serum magnesium level as a regular assessment in patients with diabetes mellitus. FAU - Kuppusamy, Santhanam AU - Kuppusamy S AD - Department of General Medicine, Government Villupuram Medical College, Mundiyambakkam, Tamilnadu, India. FAU - Dhanasinghu, Raju AU - Dhanasinghu R AD - Department of General Medicine, Government Villupuram Medical College, Mundiyambakkam, Tamilnadu, India. FAU - Sakthivadivel, Varatharajan AU - Sakthivadivel V AD - Department of General Medicine, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India. FAU - Kaliappan, Ariyanachi AU - Kaliappan A AD - Department of Anatomy, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India. FAU - Gaur, Archana AU - Gaur A AD - Department of Physiology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India. FAU - Balan, Yuvaraj AU - Balan Y AD - Department of Biochemistry, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India. FAU - Tadi, Lakshmi Jyothi AU - Tadi LJ AD - Department of Microbiology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India. FAU - Sundaramurthy, Raja AU - Sundaramurthy R AD - Department of Microbiology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India. LA - eng PT - Editorial PL - Romania TA - Maedica (Bucur) JT - Maedica JID - 101526930 PMC - PMC9720662 EDAT- 2022/12/22 06:00 MHDA- 2022/12/22 06:01 PMCR- 2022/09/01 CRDT- 2022/12/21 02:12 PHST- 2022/12/21 02:12 [entrez] PHST- 2022/12/22 06:00 [pubmed] PHST- 2022/12/22 06:01 [medline] PHST- 2022/09/01 00:00 [pmc-release] AID - 10.26574/maedica.2022.17.3.596 [doi] PST - ppublish SO - Maedica (Bucur). 2022 Sep;17(3):596-601. doi: 10.26574/maedica.2022.17.3.596.